跳至主要内容
临床试验/CTRI/2023/07/055158
CTRI/2023/07/055158招募中Unknown

An Investigator Initiated Observational study to assess the Safety & Clinical impact of Curcumin longa based Hair Serum in Indian Patients with AGA & FPHL (SCALP Study) - NA

ot applicable0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
ot applicable

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Male or female patients of 18 or above with diagnosis of hair loss
  • Hair shedding > 6 month
  • Clinical diagnosis of male AGA Grade III, Grade IV, Grade V and clinical diagnosis of FPHL Grade II and Grade III naïve cases or treated with 5% Minoxidil.
  • Patients with no known allergy.
  • Patients who agree to refrain from using hair dye, oil treatment or spa treatment, perming or straightening during the treatment/observation period
  • Patients who agree to use Non ketoconazole based shampoo

排除标准

  • Cosmetic hair treatments 1 month prior to enrolment
  • Patients with Hemoglobin level below 10.5
  • Patients with thyroid disorders or other systemic disorders including T2DM, Hypertension, HIV, Hepatitis, Anemia, Heart disorders, Cancer & undergone chemotherapy, Depression, any psychiatric disorders and those taking drugs which could cause alopecia
  • Pregnant and lactating females
  • Patients with scalp disease
  • Heavy Smokers & heavy drinkers
  • Patients on crash diets

研究者

发起方
ot applicable

相似试验

终止
3 期
Action To promote brain HEalth iN Adults (ATHENA) trial: a pilot feasibility study to determine the effects of blood pressure lowering treatment provided by a Triple Pill strategy for attenuation of cognitive decline in participants at risk for dementia.Cognitive DysfunctionCognitive ImpairmentCognitive DeclineCardiovascular - HypertensionNeurological - Other neurological disordersHypertension
ACTRN12621000121864The George Institute for Global Health6
终止
不适用
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Magnetic Resonance Imaging (MRI) Sub-study: Effect of intensive blood pressure lowering treatment provided by a Triple Pill strategy on chronic markers of cerebral small vessel disease in patients with a history of acute stroke due to intracerebral haemorrhage, as assessed by Magnetic Resonance Imaging.Stroke caused by Intracerebral Haemorrhage (ICH)Cerebral Small Vessel DiseaseStroke - HaemorrhagicCardiovascular - HypertensionNeurological - Other neurological disordersHypertension
ACTRN12618001977268The George Institute for Global Health4
已完成
4 期
An Investigator Initiated, Controlled, Prospective, Non-Inferiority, Parallel-Group, randomised, Interventional, Open, Blinded Outcome Assessment (PROBE-Design), Multi-centre Trial, Comparing Efficacy and Safety of Isolation of the Pulmonary Veins with a Cryoballoon Catheter Versus a Radiofrequency Ablation with a ThermoCool Catheter in Patients with Paroxysmal Atrial FibrillatioParoxysmal atrial fibrillationirregular heart beat10007521
NL-OMON39146FGK Representative Service GmbH114
已完成
4 期
Feasibility and Efficacy of using a non-invasive pain numbing device in Australian Blood Donor Centres - Part 1Blood Donation
ACTRN12617000950369Australian Red Cross Blood Service50
终止
不适用
Triple therapy prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study: Effectiveness of intensive long-term blood pressure lowering treatment, provided by a Triple Pill strategy, for slowing memory decline as measured by Cambridge Neuropsychological Test Automated Battery (CANTAB), in patients with a history of acute stroke due to intracerebral haemorrhage.HypertensionDementia
ACTRN12618001677291The George Institute1